Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Record and Meeting Dates for its first Annual Meeting of Stockholders
February 04, 2023 22:48 ET
|
Sorrento Therapeutics, Inc.
PALO ALTO, Calif., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), an...
Draganfly unterzeichnet strategische Vereinbarung für Entwicklung, Herstellung und den Vertrieb von Drohnen für den indischen Markt
February 04, 2023 05:27 ET
|
Draganfly Inc
LOS ANGELES, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) („Draganfly“ oder das „Unternehmen“), ein preisgekrönter, branchenführender Entwickler von...
Sorrento Distributes Dividend Confirmation Statements to 146 Brokerage Firms and Provides Specific Instruction to Continental Stock Transfer & Trust Company Regarding the Dividend of Scilex Holding Company Common Stock
February 03, 2023 20:59 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent...
LGI Homes, Inc. Reports January 2023 Home Closings
February 03, 2023 18:24 ET
|
LGI Homes, Inc.
THE WOODLANDS, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 331 homes in January 2023. As of January 31, 2023, the Company had 97 active selling...
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of December 2022
February 03, 2023 17:45 ET
|
ArrowMark Financial Corp.
DENVER, Feb. 03, 2023 (GLOBE NEWSWIRE) -- ArrowMark Financial Corp., (NASDAQ: BANX) ("ArrowMark Financial" or the “Company”), today announced that the Company’s estimated and unaudited Net Asset...
Coherus BioSciences Announces New Employment Inducement Grants
February 03, 2023 17:30 ET
|
Coherus BioSciences, Inc.
REDWOOD CITY, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective February 1, 2023, the compensation...
National Research Corporation Declares Quarterly Dividend
February 03, 2023 17:00 ET
|
National Research Corporation
Lincoln, Nebraska, Feb. 03, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve...
KVH Industries Announces Support Agreement with Black Diamond Capital Management
February 03, 2023 16:47 ET
|
KVH Industries, Inc.
Agrees to Nominate Black Diamond Managing Principal Stephen Deckoff to Board of Directors at the 2023 Annual Meeting Company Grants Black Diamond a Waiver to Purchase Up to 25% of Common Stock ...
T2 Biosystems Reports Granting of Inducement Award
February 03, 2023 16:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Feb. 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, and antibiotic resistance genes, announced today...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 03, 2023 16:30 ET
|
ORIC Pharmaceuticals
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...